Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of Immunologic Reactions During Monthly Therapy for Hansen Disease.

JAMA dermatology·2026
Same author

Aryl Hydrocarbon Receptor Expression in Cutaneous Lupus: A Clinicopathologic Correlation.

The American Journal of dermatopathology·2026
Same author

Zanubrutinib for Immunoglobulin A Vasculitis With Monoclonal Gammopathy.

JAMA dermatology·2026
Same author

Underrepresentation of Black participants in systemic sclerosis clinical trials: the U.S.A. and southeast region.

Clinical rheumatology·2025
Same author

Use of Botulinum Toxin for Advanced Tissue Ischemia.

JAMA dermatology·2025
Same author

Chronic Spontaneous Urticaria.

JAMA dermatology·2025

Related Experiment Videos

Diabetic foot ulcers: evaluation and management.

Andrea D Maderal1, Alejandra C Vivas, Thomas G Zwick

  • 1Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL.

Hospital Practice (1995)
|October 23, 2012
PubMed
Summary

Diabetic foot ulcers (DFUs) are a serious diabetes complication. Effective management requires addressing factors like hyperglycemia and infection, with standard therapies including offloading and debridement.

Related Experiment Videos

Area of Science:

  • Podiatry
  • Endocrinology
  • Vascular Medicine

Background:

  • Diabetic foot ulcers (DFUs) are a prevalent and severe complication of diabetes mellitus.
  • DFUs pose significant health risks and economic burdens.
  • Identifying factors impacting DFU healing, such as hyperglycemia, peripheral artery disease, neuropathy, and nutritional status, is crucial.

Purpose of the Study:

  • To emphasize the importance of comprehensive evaluation for factors affecting DFU healing.
  • To highlight the necessity of a multidisciplinary approach and standardized care protocols for DFU management.
  • To review current and emerging therapeutic strategies for DFUs.

Main Methods:

  • Standard DFU care involves offloading and debridement.
  • Infection assessment and control are critical components of management.
  • Adjuvant and novel therapies are considered for recalcitrant cases.

Main Results:

  • Comprehensive assessment of contributing factors is essential for optimal DFU outcomes.
  • Multidisciplinary team involvement ensures standardized and effective patient care.
  • Timely and appropriate intervention, including infection management, guides therapeutic decisions.

Conclusions:

  • Effective DFU management necessitates a holistic approach, addressing systemic health and local wound conditions.
  • Standard therapies, combined with vigilant infection control, form the cornerstone of DFU treatment.
  • Ongoing research into adjuvant and novel therapies holds promise for improving healing in complex DFUs.